MedPath

Medinova AG

Medinova AG logo
🇨🇭Switzerland
Ownership
Subsidiary
Established
1945-01-01
Employees
11
Market Cap
-
Website
http://www.medinova.ch

Clinical Trials

14

Active:8
Completed:4

Trial Phases

3 Phases

Phase 1:3
Phase 3:3
Phase 4:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (37.5%)
Phase 3
3 (37.5%)
Phase 4
2 (25.0%)

Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis

Phase 4
Terminated
Conditions
Vaginal Infection
Vaginal Diseases
Bacterial Vaginosis
Interventions
First Posted Date
2023-03-29
Last Posted Date
2024-10-16
Lead Sponsor
Medinova AG
Target Recruit Count
151
Registration Number
NCT05788991
Locations
🇨🇿

Centrum ambulantní gynekologie a primární péče, s.r.o., Brno, Czechia

🇨🇿

G-CENTRUM Olomouc s.r.o., Olomouc, Czechia

🇨🇿

GYNEKO spol. s r.o, Vsetín, Czechia

and more 11 locations

Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis

Phase 3
Withdrawn
Conditions
Vulvovaginal Candidiasis
Interventions
Device: LactiSal vaginal tablet 50mg
Device: LactiSal vaginal gel 1%
First Posted Date
2016-09-20
Last Posted Date
2019-03-08
Lead Sponsor
Medinova AG
Registration Number
NCT02907307

Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis

Phase 4
Completed
Conditions
Vulvovaginal Candidiasis
Interventions
Drug: Fluomizin vaginal tablets
Drug: Canesten vaginal tablets
First Posted Date
2014-09-17
Last Posted Date
2016-09-15
Lead Sponsor
Medinova AG
Target Recruit Count
150
Registration Number
NCT02242695
Locations
🇹🇭

Siriraj Gynaecologic ID and Female STD Unit, Department of Obstetrics & Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Bangkok Noi district, Thailand

Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis

Phase 3
Completed
Conditions
Thrombophlebitis
Phlebitis
Interventions
Drug: Hirudoid cream 0.3 % Mucopolysaccharide polysulfate
Drug: Placebo cream without active substance
First Posted Date
2013-09-16
Last Posted Date
2017-12-14
Lead Sponsor
Medinova AG
Target Recruit Count
144
Registration Number
NCT01943006
Locations
🇹🇭

Siriraj Hospital, Bangkok, Thailand

🇹🇭

Chulalongkorn Hospital, Bangkok, Thailand

🇹🇭

Rajvithi Hospital, Bangkok, Thailand

and more 1 locations

Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients

Phase 1
Completed
Conditions
Atrophic Vaginitis
Interventions
First Posted Date
2011-06-10
Last Posted Date
2024-10-11
Lead Sponsor
Medinova AG
Target Recruit Count
16
Registration Number
NCT01370551
Locations
🇧🇪

University Hospital Leuven, Leuven, Belgium

🇩🇪

Department of Obstetrics and Gynaecology, University of Regensburg, Regensburg, Germany

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.